Hongrui Lu

机构：First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Heilongjiang University

发表论文 20 篇 · 总被引 138 次 · h-index 6

代表论文

• Targeted mechanical forces enhance the effects of tumor immunotherapy by regulating immune cells in the tumor microenvironment (2023 · Cancer Biology and Medicine · 被引 42)
• Comparison of the efficacy and safety of fruquintinib and regorafenib in the treatment of metastatic colorectal cancer: A real-world study (2023 · Frontiers in Oncology · 被引 28)
• Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis (2023 · Clinical & Translational Oncology · 被引 23)
• A Novel Microsurgical Model of Cervical Lymph Node-to-Vein Anastomosis (LNVA) for Studying Brain Lymphatic Outflow (2025 · Journal of Craniofacial Surgery · 被引 13)
• Third-line treatment options in metastatic pancreatic cancer patients: a real-world study (2023 · Frontiers in Oncology · 被引 8)
• Apatinib combined with SOX regimen for conversion therapy in advanced gastric cancer patients: a retrospective cohort study (2023 · World Journal of Surgical Oncology · 被引 7)